Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

CDNA stock hub

CareDx, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CDNAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.1B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CDNA

In the news

Latest news · CDNA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E26.7

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-2.4

P25 -105.6P50 -46.5P75 -3.1

ROIC-8.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CDNA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

230

Groups with data

Currency

USD

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001217234
Company name	CareDx, Inc.
Country	United States
Country code	US
Cusip	14167L103
Employees	765
Employees Change	115%
Employees Change Percent	17.69
Enterprise value	$953.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Diagnostics & Research
IPO Date	2014-07-17
Isin	US14167L1035
Last refreshed	2026-05-10
Market cap	$1.1B
Market cap category	Small-Cap
Price	$21.85
Price currency	USD
Rev Per Employee	539,633.99x
Sector	Healthcare
Sic	8071
Symbol	CDNA
Website	https://caredx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.73%
EV Sales Forward	2.06x
EV/EBITDA	411.76x
EV/FCF	14.71x
EV/Sales	2.31x
FCF yield	5.75%
Forward P/E	26.69x
P/B ratio	3.57x
P/S ratio	2.73x
PS Forward	2.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-3.15%
EBITDA Margin	0.56%
FCF margin	15.71%
Gross margin	68.88%
Gross Profit	$284.4M
Gross Profit Growth	21.4%
Gross Profit Growth Q	49.41%
Gross Profit Growth3 Y	10.93%
Gross Profit Growth5 Y	13.81%
Net Income	$-8.2M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-1.94%
Profit Margin	-1.98%
Profit Per Employee	$-10,708
ROA	-1.8
Roa5y	-7.27
ROCE	-3.92
ROE	-2.36
Roe5y	-14.03
ROIC	-8.58
Roic5y	-47.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	17.49%
Cagr1y	47.98%
Cagr3y	37.57%
Cagr5y	-22.41%
EPS Growth Quarters	1
EPS Growth Years	0
FCF Growth	221.84%
OCF Growth	172.44%
OCF Growth5 Y	91.18%
Revenue Growth	19.17x
Revenue Growth Q	38.99x
Revenue Growth Quarters	3x
Revenue Growth Years	2x
Revenue Growth3 Y	8.9x
Revenue Growth5 Y	13.29x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.92
Assets	$411.1M
Cash	$187.2M
Current Assets	$269.4M
Current Liabilities	$79.2M
Debt	$24.5M
Debt EBITDA	$2.54
Debt Equity	$0.08
Debt FCF	$0.38
Equity	$313.5M
Liabilities	$97.5M
Long Term Assets	$141.7M
Long Term Liabilities	$18.4M
Net Cash	$173.6M
Net Cash By Market Cap	$15.4
Net Cash Growth	-13.49%
Net Debt EBITDA	$-74.95
Net Debt Equity	$-0.55
Net Debt FCF	$-2.68
Tangible Book Value	$241.1M
Tangible Book Value Per Share	$4.7
WACC	17.56

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.4
Inventory Turnover	5.21
Net Working Capital	$9.7M
Quick ratio	2.93
Working Capital	$190.2M
Working Capital Turnover	$1.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	9.13%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	401.15%
1Y total return	47.94%
200-day SMA	16.98
3Y total return	160.43%
50-day SMA	18.82
50-day SMA vs 200-day SMA	50over200
5Y total return	-71.88%
All Time High	99.83
All Time High Change	-78.11%
All Time High Date	2021-01-20
All Time Low	0.76
All Time Low Change	2,775%
All Time Low Date	2017-04-28
ATR	1.39
Beta	2.49
Beta1y	1.32
Beta2y	1.28
Ch YTD	15.98
High	22.25
High52	23.24
High52 Date	2026-04-17
High52ch	-5.98%
Low	21.01
Low52	10.96
Low52 Date	2025-07-17
Low52ch	99.36%
Ma50ch	16.12%
Premarket Change Percent	0.33
Premarket Price	$21.51
Premarket Volume	15,826
Price vs 200-day SMA	28.65%
RSI	60.96
RSI Monthly	54.83
RSI Weekly	63.17
Sharpe ratio	0.87x
Sortino ratio	1.32
Total Return	9.13%
Tr YTD	15.98
Tr1m	23.66%
Tr1w	1.63%
Tr3m	12.22%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Ratings	Buy
Earnings EPS Estimate	$0.08
Earnings EPS Estimate Growth	-11.11
Earnings Revenue Estimate	105,502,000x
Earnings Revenue Estimate Growth	24.58x
Operating Income	$-13M
Operating margin	-3.15
Price target	$28
Price Target Change	$28.15

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	49,476,772%
Float Percent	95.77%
Shares Insiders	4.23%
Shares Institutions	99.92%
Shares Out	51,659,481
Shares Qo Q	3.92%
Shares Yo Y	-9.13%
Short Float	12.93%
Short Ratio	10.45
Short Shares	12.38

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$29.1M
Average Volume	847,278.05x
Bv Per Share	6.11
CAPEX	$-8.1M
Ch10y	401.1
Ch1m	23.66
Ch1w	1.63
Ch1y	47.94
Ch3m	12.22
Ch3y	160.4
Ch5y	-71.88
Ch6m	39.89
Change	1.91%
Change From Open	2.1
Close	21.44
Days Gap	-0.19
Depreciation Amortization	15,317,000
Dollar Volume	15,115,895.6
Earnings Date	2026-04-28
Earnings Time	amc
EBIT	$-13M
EBITDA	$2.3M
EPS	$-0.16
F Score	4
FCF	$64.8M
FCF EV Yield	6.8x
FCF Per Share	$1.26
Financing CF	-95,662,000
Fiscal Year End	December
Founded	1,998
Goodwill	40,336,000
Income Tax	$181,000
Investing CF	11,892,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-25
Ma150	18.21
Ma150ch	19.98%
Ma20	20.63
Ma20ch	5.92%
Net CF	-10,821,000
Next Earnings Date	2026-08-05
Open	21.4
Optionable	Yes
P FCF Ratio	17.38
P OCF Ratio	15.45
Position In Range	67.74
Post Close	21.85
Postmarket Change Percent	-0.14
Postmarket Price	$21.82
Ppne	54,362,000
Pre Close	21.44
Price Date	2026-05-08
Price EBITDA	$487
Ptbv Ratio	4.68
Relative Volume	0.82x
Revenue	412,820,000x
SBC By Revenue	8.66x
Share Based Comp	35,736,000
Tax By Revenue	0.04x
Tr6m	39.89%
Us State	California
Volume	691,803
Z Score	4.5

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CDNA pay a dividend?

Capital-return profile for this ticker.

Performance

CDNA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CDNA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+99.9%

Float: +95.8% of shares outstanding

Insider ownership

+4.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CDNA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

61.0

Neutral momentum band

Price vs 200-day MA

+28.7%

50/200-day relationship not available

Beta (5Y)

2.49

More volatile than the market

Sharpe ratio

0.87

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CDNA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CDNA stock rating?

CareDx, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CDNA analysis?

The full report lives at /stocks/CDNA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CDNA?

The latest report frames CDNA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CDNA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.